Table 2.

Characteristics of the study population, according to the occurrence or not of restenosis (n = 54)

Parameter	Univariate analysis			Multivariate analysis
	Re-PCI		p	OR [95% CI]	p
	Yes (n = 4)	No (n = 50)
Age (years), median [IQR]	59.5 [58.2–60.7]	60 [57.7–63]	0.714
Sex, no. (%)			0.386
M	4 (100)	42 (84)
F	0 (−)	8 (16)
BMI, kg/m2, median [IQR]	25.3 [24.8–26.7]	27.2 [25.8–28.1]	0.159
Blood pressure (mmHg), median [IQR]
Systolic	130 [115–137.5]	130 [120–131.2]	1.000
Diastolic	80 [72.5–80]	80 [70–80]	0.714
Hypertension, no. (%)	1 (25)	14 (28)	0.897
Smoke, no. (%)	4 (100)	39 (78)	0.293
Cholesterol (mg/dL), median [IQR]
Total	157 [147.5–180.7]	174.5 [147.5–192]	0.555
HDL	34.5 [31.7–41]	43 [35–51.2]	0.066
LDL	90.5 [86–116]	109 [70.2–122.5]	0.874
Triglycerides (mg/dL), median [IQR]	141.5 [121.5–166.7]	125.5 [103–151.5]	0.327
Glycemia (mg/dL), median [IQR]
Baseline	93.5 [86.2–102.2]	87 [79.7–90]	0.066
2 h	132.5 [117.7–136.7]	106 [93–123]	0.021
Glycated hemoglobin (%), median [IQR]	5.6 [5.3–5.8]	5.2 [5–5.5]	0.051
Insulin (µU/mL), median [IQR]	9.8 [9.4–10]	3.6 [2.8–4.7]	0.003
HOMA IR, median [IQR]	2.23 [2.1–2.4]	0.75 [0.57–0.97]	0.003
Creatinine (mg/dL), median [IQR]	1 [1–1.16]	1 [0.8–1.1]	0.266
Hemoglobin (mg/dL), median [IQR]	14.2 [13.2–14.5]	14.3 [13.3–15.2]	0.534
Adiponectin (µg/mL), median [IQR]	7 [6–8]	11.5 [10–14]	0.000	0.206 [0.053–0.796]	0.022
Resistin (ng/mL), median [IQR]	13 [5.2–15.5]	6.5 [4–8.2]	0.137
TNF-alpha (ng/mL), median [IQR]	18.5 [11–20.7]	8 [7–10]	0.008
Time RE-PCI, median [IQR]	8.5 [4–21.2]	29.5 [13.5–34]	0.019
Follow-up duration (months), median [IQR]	30 [25.7–32.7]	29.5 [13.5–34]	1.000
Death, no. (%)
Cardiovascular/other causes	0 (−)/−	0 (−)/1 (2)	0.775